<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-07T11:10:41+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>本周 6 款注射剂过评，3 款为首家</title>
    <updated>2020-11-06T18:03:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/aYc1Ja52K5VhDm_ZhKv_wQ</id>
    <link href="https://mp.weixin.qq.com/s/aYc1Ja52K5VhDm_ZhKv_wQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百元支架时代开启！我们真要实现「支架自由」了吗？</title>
    <updated>2020-11-06T18:03:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/aciJgfQ3m8WfgegNdr6-1w</id>
    <link href="https://mp.weixin.qq.com/s/aciJgfQ3m8WfgegNdr6-1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药新股破发频频，投资逻辑生变？</title>
    <updated>2020-11-06T14:46:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/iFgOCOhGJ0gFxf_UlDHhtA</id>
    <link href="https://mp.weixin.qq.com/s/iFgOCOhGJ0gFxf_UlDHhtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一线治疗鼻咽癌！恒瑞 PD-1 第 6 个适应症拟纳入优先审评</title>
    <updated>2020-11-06T14:46:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/KjcoUQLnQ3ngCE44M7XonQ</id>
    <link href="https://mp.weixin.qq.com/s/KjcoUQLnQ3ngCE44M7XonQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州三季报，PD-1 卖了 3.3 亿元</title>
    <updated>2020-11-06T14:46:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/yKmRXIb1EtxKCBaK0e10jQ</id>
    <link href="https://mp.weixin.qq.com/s/yKmRXIb1EtxKCBaK0e10jQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架集采拟中选结果公布！均价1.3万降到 700 元</title>
    <updated>2020-11-05T14:26:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/PrRJx4NItdzVHdEGzUP7xQ</id>
    <link href="https://mp.weixin.qq.com/s/PrRJx4NItdzVHdEGzUP7xQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球销售额15亿美元，青峰药业「拉考沙胺注射液」首仿获批</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/aWfVUyWuAzjMyCE0obS4Rw</id>
    <link href="https://mp.weixin.qq.com/s/aWfVUyWuAzjMyCE0obS4Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10 亿重磅品种，扬子江药业「注射用泮托拉唑钠」第二家过评</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/fELo8iGvUI31-4X07FHUoA</id>
    <link href="https://mp.weixin.qq.com/s/fELo8iGvUI31-4X07FHUoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>苑东生物「格隆溴铵注射液」获批上市，国内第二家</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/lAajZdFtX3G_eIJOyhb10w</id>
    <link href="https://mp.weixin.qq.com/s/lAajZdFtX3G_eIJOyhb10w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州「迪妥昔单抗」报上市，已纳入优先审评</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/s4pADZeuWkZTzvLUHz_ryw</id>
    <link href="https://mp.weixin.qq.com/s/s4pADZeuWkZTzvLUHz_ryw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>无法足量供应！第三批集采两品种增加 3 个月过渡期，同步核减采购量</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/hQ4Wl5_nb2Pnt1zCMAlStg</id>
    <link href="https://mp.weixin.qq.com/s/hQ4Wl5_nb2Pnt1zCMAlStg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森 NASH 新药启动临床</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/DPZ3w2xomqGnLjY-OQLzLg</id>
    <link href="https://mp.weixin.qq.com/s/DPZ3w2xomqGnLjY-OQLzLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最后三天免费报名：上海药物开发者合作大会开幕在即</title>
    <updated>2020-11-04T16:12:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/squOJfQPBX_FhJgU4ZasBQ</id>
    <link href="https://mp.weixin.qq.com/s/squOJfQPBX_FhJgU4ZasBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这 25 个品种危险了！过评满 3 家，多个 20 亿重磅品种在列</title>
    <updated>2020-11-03T18:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/DofDHhKnhWZgIpXD8LxzRQ</id>
    <link href="https://mp.weixin.qq.com/s/DofDHhKnhWZgIpXD8LxzRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有望拿下首个国产 1 类 CAR-T 疗法，药明巨诺正式登陆港交所</title>
    <updated>2020-11-03T18:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/121Tu_-32OkmGUH1O49K7w</id>
    <link href="https://mp.weixin.qq.com/s/121Tu_-32OkmGUH1O49K7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超级抗流感新药！罗氏 Xofluza 上市申请拟纳入优先审评</title>
    <updated>2020-11-03T18:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/JdUvLTo9E2JX5eZs36WPFg</id>
    <link href="https://mp.weixin.qq.com/s/JdUvLTo9E2JX5eZs36WPFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床急需品种「布罗索尤单抗注射液」拟纳入优先审评，用于肿瘤相关骨软化症</title>
    <updated>2020-11-03T18:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/TvqZZ4uTt5T2oKCdDYhmGA</id>
    <link href="https://mp.weixin.qq.com/s/TvqZZ4uTt5T2oKCdDYhmGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>城会玩！2020新原力论坛告诉你，什么叫生物界与艺术界的融合</title>
    <updated>2020-11-03T18:08:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/LgM6w2FzjIS2rU7x4C19SQ</id>
    <link href="https://mp.weixin.qq.com/s/LgM6w2FzjIS2rU7x4C19SQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「注射用艾司奥美拉唑钠」首家过评！30 亿大市场迎来新变数</title>
    <updated>2020-11-02T11:55:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/AJQaMocjdqIbT8zsORqrSw</id>
    <link href="https://mp.weixin.qq.com/s/AJQaMocjdqIbT8zsORqrSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康「注射用泮托拉唑钠」首家过评</title>
    <updated>2020-11-02T11:55:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/G8advS267m2yDalF0xfKFg</id>
    <link href="https://mp.weixin.qq.com/s/G8advS267m2yDalF0xfKFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>